# Current use and safety of novel oral anticoagulants in adults with congenital heart disease: results of a nationwide analysis including more than 44 000 patients

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/current-use-and-safety-of-novel-oral-anticoagulants-in-adults-with-congenital/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Eva Freisinger,Joachim Gerß,Lena Makowski,Ursula Marschall,Holger Reinecke,Helmut Baumgartner,Jeanette Koeppe,Gerhard‐Paul Diller |
| Citations | 70 |
| DOI | 10.1093/eurheartj/ehaa844 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://academic.oup.com/eurheartj/article-pdf/41/43/4168/34674209/ehaa844.pdf |
| OpenAlex ID | https://openalex.org/W3106431674 |
| PMID | 33184662 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Eva Freisinger](https://scholariq.org/researchers/eva-freisinger/)

## Paper journal

- [European Heart Journal](https://scholariq.org/journals/european-heart-journal/)

## Paper primary topic

- [Cardiac Arrhythmias and Treatments](https://scholariq.org/topics/cardiac-arrhythmias-and-treatments/)

## Paper topics

- [Cardiac Arrhythmias and Treatments](https://scholariq.org/topics/cardiac-arrhythmias-and-treatments/)
- [Congenital Heart Disease Studies](https://scholariq.org/topics/congenital-heart-disease-studies/)
- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.